From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

Decision Making in Doxy-PEP

First published:

March 2025

Last published:

June 2025

Overview

The Doxy-PEP Decision Making Tool supports prescribing doxycycline post-exposure prophylaxis (Doxy-PEP) to gay and bisexual men and transgender women at increased risk of syphilis. Suitable patients include those with recent syphilis or other STI diagnoses, periods of increased risk, or who wish to protect partners, provided there are no contraindications. Doxy-PEP should be part of a broader sexual health approach, including regular STI and HIV testing, vaccinations, and ongoing review of its need.

ASHM would like to thank Dr Nicholas Medland and the clinicians who advised on and reviewed this resource.

Related Resource: NSW Health Doxy-PEP Decision-aid for consumers tool